A detailed history of Intech Investment Management LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 17,345 shares of AXGN stock, worth $410,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,345
Previous 29,278 40.76%
Holding current value
$410,209
Previous $317,000 2.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$10.77 - $17.84 $128,518 - $212,884
-11,933 Reduced 40.76%
17,345 $309,000
Q2 2025

Aug 08, 2025

BUY
$9.29 - $17.81 $43,895 - $84,152
4,725 Added 19.24%
29,278 $317,000
Q1 2025

May 20, 2025

BUY
$14.56 - $20.11 $117,892 - $162,830
8,097 Added 49.2%
24,553 $454,000
Q4 2024

Feb 10, 2025

BUY
$12.47 - $17.19 $51,638 - $71,183
4,141 Added 33.63%
16,456 $271,000
Q3 2024

Nov 08, 2024

BUY
$7.52 - $14.69 $92,608 - $180,907
12,315 New
12,315 $172,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $1B
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.